Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 11/2010

01.11.2010 | Head and Neck

Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients

verfasst von: Shigenari Taki, Akihiro Homma, Nobuhiko Oridate, Seigo Suzuki, Fumiyuki Suzuki, Tomohiro Sakashita, Satoshi Fukuda

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

This retrospective study aimed to assess the role of salvage surgery for local recurrence in hypopharyngeal cancer (HPC) patients who had received radiotherapy (RT) or concomitant chemoradiotherapy (CRT) as an initial treatment. The local recurrence rate, salvage rate after local recurrence and overall survival rate were investigated in 104 HPC patients who received treatment between 1991 and 2005. Local recurrence in the primary site was observed in 41 patients (rate, 39.4%) of whom only 12 could undergo further salvage surgery. Disease control was achieved in seven of these patients (successful salvage rate, 17.1%). The 5-year overall survival rate was 40.6% in the RT/CRT patient group and successful salvage rates for T1, T2, T3 and T4 primary disease were 33.3% (1/3), 20.0% (4/20), 16.7% (2/12) and 0% (0/6), respectively. Severe postoperative complications such as pharyngo-cutaneous fistula were seen in six patients (50.0%). Prognosis of patients with locally recurring HPC after RT/CRT is poor at any primary T-stage and the incidence of postoperative complication is relatively high. This should be taken into consideration when the initial treatment plan is decided and the choice of salvage surgery for such recurrent cases should be carefully determined.
Literatur
1.
Zurück zum Zitat Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group. (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiather Oncol 92(1):4–14CrossRef Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group. (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiather Oncol 92(1):4–14CrossRef
2.
Zurück zum Zitat Bernier J, Schneider D (2007) Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck? Eur J Cancer 43:35–45CrossRefPubMed Bernier J, Schneider D (2007) Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck? Eur J Cancer 43:35–45CrossRefPubMed
3.
Zurück zum Zitat Bernier J (2008) A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update. Curr Opin Oncol 20:249–255CrossRefPubMed Bernier J (2008) A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update. Curr Opin Oncol 20:249–255CrossRefPubMed
4.
Zurück zum Zitat Robbins KT, Vicario D, Seagren S, Weisman R, Pellitteri R, Kerber C, Orloff L, Los G, Howell SB (1994) A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 168:419–422CrossRefPubMed Robbins KT, Vicario D, Seagren S, Weisman R, Pellitteri R, Kerber C, Orloff L, Los G, Howell SB (1994) A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 168:419–422CrossRefPubMed
5.
Zurück zum Zitat Soo K-C, Tan E-H, Wee J, Lim D, Tai B-C, Khoo M-L, Goh C, Leong S-S, Tan T, Fong K-W, Lu P, See A, Machin D (2005) Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 93:279–286CrossRefPubMed Soo K-C, Tan E-H, Wee J, Lim D, Tai B-C, Khoo M-L, Goh C, Leong S-S, Tan T, Fong K-W, Lu P, See A, Machin D (2005) Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 93:279–286CrossRefPubMed
6.
Zurück zum Zitat Bahadur S, Thakar A, Mohanti BK, Lal P (2002) Results of radiotherapy with, or without, salvage surgery versus combined surgery and radiotherapy in advanced carcinoma of the hypopharynx. J Laryngol Otol 116:29–32CrossRefPubMed Bahadur S, Thakar A, Mohanti BK, Lal P (2002) Results of radiotherapy with, or without, salvage surgery versus combined surgery and radiotherapy in advanced carcinoma of the hypopharynx. J Laryngol Otol 116:29–32CrossRefPubMed
7.
Zurück zum Zitat Richey LM, Shores CG, George J, Lee S, Couch MJ, Sutton DK, Weissler MC (2007) The effectiveness of salvage surgery after the failure of primary concomitant chemoradiation in head and neck cancer. Otolaryngol Head Neck Surg 136:98–103CrossRefPubMed Richey LM, Shores CG, George J, Lee S, Couch MJ, Sutton DK, Weissler MC (2007) The effectiveness of salvage surgery after the failure of primary concomitant chemoradiation in head and neck cancer. Otolaryngol Head Neck Surg 136:98–103CrossRefPubMed
8.
Zurück zum Zitat Lee SC, Shores CG, Weissler MC (2008) Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg 16:135–140CrossRefPubMed Lee SC, Shores CG, Weissler MC (2008) Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg 16:135–140CrossRefPubMed
9.
Zurück zum Zitat Leon X, Quer M, Orus C, Lopez M, Gras JR, Vega M (2001) Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy. Head Neck 23:733–738CrossRefPubMed Leon X, Quer M, Orus C, Lopez M, Gras JR, Vega M (2001) Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy. Head Neck 23:733–738CrossRefPubMed
10.
Zurück zum Zitat Stoeckli SJ, Pawlik AB, Lipp M, Huber A, Schmid S (2000) Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg 126:1473–1477PubMed Stoeckli SJ, Pawlik AB, Lipp M, Huber A, Schmid S (2000) Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg 126:1473–1477PubMed
11.
Zurück zum Zitat Proctor E, Robbins KT, Vieira F, Hanchett C, Sommes G (2004) Postoperative complications after chemoradiation for advanced head and neck cancer. Head Neck 26:272–277CrossRefPubMed Proctor E, Robbins KT, Vieira F, Hanchett C, Sommes G (2004) Postoperative complications after chemoradiation for advanced head and neck cancer. Head Neck 26:272–277CrossRefPubMed
12.
Zurück zum Zitat Clark JR, de Almeida J, Gilbert R, Irish J, Brown D, Neligan P, Gullane PJ (2006) Primary and salvage (hypo) pharyngectomy: analysis and outcome. Head Neck 28:671–677CrossRefPubMed Clark JR, de Almeida J, Gilbert R, Irish J, Brown D, Neligan P, Gullane PJ (2006) Primary and salvage (hypo) pharyngectomy: analysis and outcome. Head Neck 28:671–677CrossRefPubMed
13.
Zurück zum Zitat Wakisaka N, Murono S, Kondo S, Furykawa M, Yoshizaki T (2008) Post-operative pharyngocutaneous fistula after laryngectomy. Auris Nasus Larynx 35:203–208CrossRefPubMed Wakisaka N, Murono S, Kondo S, Furykawa M, Yoshizaki T (2008) Post-operative pharyngocutaneous fistula after laryngectomy. Auris Nasus Larynx 35:203–208CrossRefPubMed
Metadaten
Titel
Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients
verfasst von
Shigenari Taki
Akihiro Homma
Nobuhiko Oridate
Seigo Suzuki
Fumiyuki Suzuki
Tomohiro Sakashita
Satoshi Fukuda
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 11/2010
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-010-1274-3

Weitere Artikel der Ausgabe 11/2010

European Archives of Oto-Rhino-Laryngology 11/2010 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.